Optimer's Dificid approved in Canada for Clostridium difficile infection
12:05 EDT 6 Jul 2012 | SCRIP
Health Canada approved Optimer Pharmaceuticals' Dificid (fidaxomicin) for the treatment of Clostridium difficile infection (CDI) in adults, making the San Diego company's antibiotic the first new drug approved to treat CDI in.....
Original Article: Optimer's Dificid approved in Canada for Clostridium difficile infection
More From BioPortfolio on "Optimer's Dificid approved in Canada for Clostridium difficile infection"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
